NTLA

Intellia Therape

• Seeking Alpha·05/18 10:50

  Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM

• TipRanks·05/14 12:09

  J.P. Morgan Remains a Sell on Intellia Therapeutics (NTLA)

• Dow Jones·05/13 18:49

  Intellia Therapeutics Price Target Raised to $17.00/Share From $13.00 by Bernstein

• Dow Jones·05/13 18:49

  Intellia Therapeutics Is Maintained at Market Perform by Bernstein

• Benzinga·05/13 18:39

  Bernstein Maintains Market Perform on Intellia Therapeutics, Raises Price Target to $17

• TipRanks·05/13 13:50

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), TriSalus Life Sciences (TLSI) and Fractyl Health, Inc. (GUTS)

• Benzinga·05/13 13:03

  Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

• Dow Jones·05/13 11:15

  Intellia Therapeutics Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·05/13 11:15

  Intellia Therapeutics Price Target Cut to $25.00/Share From $30.00 by HC Wainwright & Co.

• Benzinga·05/13 11:05

  HC Wainwright & Co. Maintains Buy on Intellia Therapeutics, Lowers Price Target to $25

• TipRanks·05/13 10:28

  Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright

• Reuters·05/13 10:14

  INTELLIA THERAPEUTICS, INC. <NTLA.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $25 FROM $30

• TipRanks·05/13 08:54

  Wells Fargo Remains a Hold on Intellia Therapeutics (NTLA)

• Reuters·05/13 07:31

  U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic

• Seeking Alpha·05/13 03:54

  Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update